0001683168-19-001919.txt : 20190617 0001683168-19-001919.hdr.sgml : 20190617 20190617162012 ACCESSION NUMBER: 0001683168-19-001919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190605 FILED AS OF DATE: 20190617 DATE AS OF CHANGE: 20190617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dye Justin CENTRAL INDEX KEY: 0001654539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55450 FILM NUMBER: 19901619 MAIL ADDRESS: STREET 1: C/O MEDICINE MAN TECHNOLOGIES, INC. STREET 2: 4880 HAVANA STREET, SUITE 201 CITY: DENVER STATE: CO ZIP: 80239 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medicine Man Technologies, Inc. CENTRAL INDEX KEY: 0001622879 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 465289499 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4880 HAVANA STREET STREET 2: SUITE 102 SOUTH CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: 303-371-0387 MAIL ADDRESS: STREET 1: 4880 HAVANA STREET STREET 2: SUITE 102 SOUTH CITY: DENVER STATE: CO ZIP: 80239 4 1 ownership.xml X0306 4 2019-06-05 0 0001622879 Medicine Man Technologies, Inc. MDCL 0001654539 Dye Justin C/O MEDICINE MAN TECHNOLOGIES, INC. 4880 HAVANA STREET, SUITE 201 DENVER CO 90239 1 0 0 0 Common Stock 2019-06-05 4 P 0 1500000 2.00 A 1500000 I See footnote 1 Option to purchase common stock 3.72 2019-06-05 4 A 0 300000 0 A 2019-06-05 2022-06-05 Common Stock 300000 300000 D Warrant to purchase common stock 3.50 2019-06-05 4 P 0 1500000 A 2019-06-05 2022-06-05 Common Stock 1500000 1500000 I See footnote 1 On June 5, 2019, Medicine Man Technologies, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with Dye Capital Cann Holdings, LLC (the "Investor"). The Reporting Person has voting and investment control of the securities owned by the Investor and disclaims beneficial ownership of the securities for purposes of Section 16 except to the extent of the Reporting Person's pecuniary interest therein. Pursuant to the Purchase Agreement, the Investor purchased, in a private placement 1,500,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock") at a price of $2.00 per share and warrants (the "Warrants") to purchase 1,500,000 shares of Common Stock. The Warrants are for a term of three years and are exercisable at a price of $3.50. The Option vests in 1/2 increments on the one (1) and two (2) year anniversaries of the date of grant. /s/ Justin Dye 2019-06-14